Kyle Gano Neurocrine Biosciences Inc (NBIX) insider trading activity

NBIX Quotes by TradingView

Kyle Gano is Chief Executive Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 135,392 shares of NBIX, which is worth approximately $19.4 Million. The most recent transaction as insider was on Jan 15, 2025, when has been sold 65,000 shares (Common Stock) at a price of $141.5 per share, resulting in proceeds of $9,197,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 135K
0.17% 3M change
3.95% 12M change
Total Value Held $19.4 Million

Kyle Gano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 15 2025
SELL
Open market or private sale
$9,197,500 $141.5 p/Share
65,000 Reduced 32.44%
135,392 Common Stock
Jan 15 2025
BUY
Exercise of conversion of derivative security
$2,144,350 $32.99 p/Share
65,000 Added 24.94%
195,580 Common Stock
Feb 13 2024
SELL
Open market or private sale
$179,667 $132.89 p/Share
1,352 Reduced 0.99%
135,166 Common Stock
Feb 08 2024
SELL
Open market or private sale
$131,516 $134.2 p/Share
980 Reduced 0.73%
133,952 Common Stock
Feb 06 2024
SELL
Open market or private sale
$227,519 $142.2 p/Share
1,600 Reduced 1.19%
133,072 Common Stock
Jan 31 2024
SELL
Open market or private sale
$216,818 $140.7 p/Share
1,541 Reduced 1.16%
131,635 Common Stock
Jan 02 2024
SELL
Open market or private sale
$9,859,500 $131.46 p/Share
75,000 Reduced 36.54%
130,250 Common Stock
Jan 02 2024
BUY
Exercise of conversion of derivative security
$1,469,250 $19.59 p/Share
75,000 Added 35.48%
136,366 Common Stock
Aug 21 2023
SELL
Open market or private sale
$228,998 $107.41 p/Share
2,132 Reduced 1.61%
130,250 Common Stock
Feb 08 2023
SELL
Open market or private sale
$101,910 $103.99 p/Share
980 Reduced 0.76%
128,096 Common Stock
Feb 07 2023
SELL
Open market or private sale
$1,476,296 $102.35 p/Share
14,424 Reduced 10.18%
127,216 Common Stock
Feb 06 2023
SELL
Open market or private sale
$169,024 $105.64 p/Share
1,600 Reduced 1.38%
114,257 Common Stock
Jan 31 2023
SELL
Open market or private sale
$169,479 $109.98 p/Share
1,541 Reduced 1.35%
112,820 Common Stock
Feb 08 2022
SELL
Open market or private sale
$78,077 $79.67 p/Share
980 Reduced 0.87%
111,173 Common Stock
Feb 07 2022
SELL
Open market or private sale
$476,484 $80.76 p/Share
5,900 Reduced 5.08%
110,294 Common Stock
Jan 05 2022
SELL
Open market or private sale
$2,416,743 $85.5 p/Share
28,266 Reduced 21.21%
104,984 Common Stock
Jan 05 2022
BUY
Exercise of conversion of derivative security
$244,784 $8.66 p/Share
28,266 Added 17.5%
133,250 Common Stock
Feb 08 2021
SELL
Open market or private sale
$431,527 $116.85 p/Share
3,693 Reduced 3.4%
104,768 Common Stock
Feb 05 2021
SELL
Open market or private sale
$304,991 $113.93 p/Share
2,677 Reduced 2.6%
100,439 Common Stock
Nov 12 2020
SELL
Open market or private sale
$204,778 $90.73 p/Share
2,257 Reduced 2.25%
98,028 Common Stock
KG

Kyle Gano

Chief Executive Officer
San Diego, CA

Track Institutional and Insider Activities on NBIX

Follow NEUROCRINE BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBIX